Concepedia

Publication | Open Access

Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity from a Phase I Study of Simlukafusp Alfa (FAP-IL2v) in Advanced/Metastatic Solid Tumors

DOIFull Paper Access

22

Citations

13

References

2024

Year

Neeltje Steeghs, Carlos Gomez‐Roca, Kristoffer Staal Rohrberg, Morten Mau‐Sørensen, Debbie Robbrecht, Josep Tabernero, Samreen Ahmed, María E. Rodríguez-Ruiz, Caroline Ardeshir, Daniela Schmid,
Clinical Cancer Research

Abstract

FAP-IL2v had a manageable safety profile and showed initial signs of antitumor activity in advanced/metastatic solid tumors.

References

YearCitations

Page 1